Select Medical (NYSE:SEM) Raised to Buy at StockNews.com

Select Medical (NYSE:SEM) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Tuesday.

SEM has been the subject of several other reports. Benchmark downgraded Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, November 25th. Bank of America began coverage on Select Medical in a research note on Tuesday, August 20th. They issued a “buy” rating and a $42.00 price objective for the company. Finally, Royal Bank of Canada increased their price objective on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th.

Select Medical Trading Down 0.2 %

NYSE:SEM opened at $20.52 on Tuesday. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. Select Medical has a 1-year low of $19.82 and a 1-year high of $40.98. The firm has a market capitalization of $2.66 billion, a price-to-earnings ratio of 9.59, a price-to-earnings-growth ratio of 0.47 and a beta of 1.43. The stock has a fifty day simple moving average of $33.24 and a 200 day simple moving average of $34.43.

Select Medical (NYSE:SEM) last released its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.07. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. Select Medical’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter last year, the company posted $0.46 EPS. Sell-side analysts forecast that Select Medical will post 1.74 earnings per share for the current year.

Insider Transactions at Select Medical

In related news, Director Marilyn B. Tavenner sold 32,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total value of $674,880.00. Following the transaction, the director now directly owns 22,000 shares of the company’s stock, valued at approximately $463,980. This trade represents a 59.26 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 17.50% of the company’s stock.

Institutional Trading of Select Medical

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SEM. Hexagon Capital Partners LLC grew its holdings in shares of Select Medical by 528.7% during the 2nd quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock worth $27,000 after purchasing an additional 645 shares in the last quarter. Quarry LP acquired a new stake in shares of Select Medical during the 3rd quarter worth approximately $30,000. Transcendent Capital Group LLC acquired a new stake in shares of Select Medical during the 2nd quarter worth approximately $35,000. Canada Pension Plan Investment Board acquired a new stake in shares of Select Medical during the 2nd quarter worth approximately $39,000. Finally, DekaBank Deutsche Girozentrale acquired a new stake in shares of Select Medical during the 2nd quarter worth approximately $60,000. Institutional investors and hedge funds own 89.48% of the company’s stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.